Bo-Inge Hansson
Profile
Bo-Inge Hansson was a Managing Director & Board Member at Sista Versen 8666.
AB and a Director at Gambro AB.
Former positions of Bo-Inge Hansson
| Companies | Position | End |
|---|---|---|
Sista Versen 8666 AB
 Sista Versen 8666 AB Pharmaceuticals: MajorHealth Technology Sista versen 8666 AB offers solutions for the cancer clinics. The firm develops systems for electrochemotherapy. Its product Cliniporator is used to fight cutaneous and sub-cuteaneous metastasies by increasing the effect of chemotherapeutic drugs, offering an alternative to traditional radiation therapy and surgery. The company was founded on September 14, 2006 and is headquartered in Lund, Sweden. | President | 15/03/2010 |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
Sista Versen 8666 AB
Sista Versen 8666 AB Pharmaceuticals: MajorHealth Technology Sista versen 8666 AB offers solutions for the cancer clinics. The firm develops systems for electrochemotherapy. Its product Cliniporator is used to fight cutaneous and sub-cuteaneous metastasies by increasing the effect of chemotherapeutic drugs, offering an alternative to traditional radiation therapy and surgery. The company was founded on September 14, 2006 and is headquartered in Lund, Sweden. | Health Technology |
- Stock Market
- Insiders
- Bo-Inge Hansson
